Results 161 to 170 of about 26,023 (245)

Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?

, 2011
John Steele, Sam Gandy
openalex   +2 more sources

The synthesis of tritiated (R)‐2‐methoxy‐N‐n‐propyl‐nor‐apomorphine (MNPA) [PDF]

, 2007
Jonas Malmquist, Susanne Olofsson, Peter Ström   +2 more
openalex   +1 more source

Estimation of Dopamine D₁ Receptor Agonist Binding Kinetics Using Time-Resolved Functional Assays: Relation to Agonist-Induced Receptor Internalization by Investigational Antiparkinsonian Therapeutics. [PDF]

ACS Chem Neurosci
Sahlholm K, Svensson P, Malo M, Andersson DR, Betari N.   +4 more
europepmc   +1 more source

Apomorphine [PDF]

The Journal of Nervous and Mental Disease, 1876
openaire   +1 more source

Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders. [PDF]

CNS Drugs
Detyniecki K, Strzelczyk A, Roebling R, Laloyaux C, Chanteux H, Cloyd JC.   +5 more
europepmc   +1 more source

Inducing emesis in Australian dogs and cats: agents, adverse effects and antiemetic administration. [PDF]

Aust Vet J
Tsitonakis J, Hall E, Quain A.
europepmc   +1 more source

Subcutaneous apomorphine in the treatment of Parkinson's disease. [PDF]

, 1990
J P Frankel, Andrew J. Lees, Peter Kempster, G M Stern   +3 more
openalex   +1 more source

Measurement of Glutamate Suppression in a 6-OHDA-Induced Dopamine Deficiency Rat Model Following Acute Single-Dose L-DOPA Using GluCEST/MRS. [PDF]

Biomedicines
Nakano T, Bono K, Ueda J, Ohmi M, Saito S.   +4 more
europepmc   +1 more source

Targeting the hypothalamic a11 nucleus to treat parkinsonian-like nociceptive impairments. [PDF]

NPJ Parkinsons Dis
Charles KA, Bouali-Benazzouz R, Naudet F, Aby F, Fossat P, Benazzouz A.   +5 more
europepmc   +1 more source

Apomorphine effects on frog locomotor behavior

, 2007
Joanne Chu, Walter Wilczynski
openalex   +1 more source